MARKET

CAPR

CAPR

Capricor Therapeutics Inc
NASDAQ
19.40
+0.28
+1.46%
Opening 11:16 07/17 EDT
OPEN
18.77
PREV CLOSE
19.12
HIGH
19.79
LOW
18.66
VOLUME
350.84K
TURNOVER
--
52 WEEK HIGH
40.37
52 WEEK LOW
4.300
MARKET CAP
1.12B
P/E (TTM)
-8.3874
1D
5D
1M
3M
1Y
5Y
1D
Capricor Therapeutics (CAPR) Signs Expansion Lease Tied To Deramiocel FDA Approval
Simply Wall St · 14h ago
Capricor Therapeutics Signs Strategic Headquarters Lease Agreement
TipRanks · 2d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 3d ago
Weekly Report: what happened at CAPR last week (0706-0710)?
Weekly Report · 4d ago
Relative Strength Alert For Capricor Therapeutics
NASDAQ · 6d ago
Capricor Therapeutics (CAPR) Is Down 5.8% After FDA Adcom Set, Russell Exit News - Has The Bull Case Changed?
Simply Wall St · 07/07 19:38
Capricor Therapeutics (CAPR) Gets a Buy from Cantor Fitzgerald
TipRanks · 07/07 11:25
Weekly Report: what happened at CAPR last week (0629-0703)?
Weekly Report · 07/06 09:36
More
About CAPR
Capricor Therapeutics, Inc. is a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases. The Company's program focuses on the development and commercialization of a cell therapy technology comprised of cardiosphere-derived cells (CDCs) for the treatment of Duchenne muscular dystrophy (DMD). Its lead product candidate, Deramiocel (also referred to as CAP-1002), is an allogeneic cardiac-derived cell therapy. The clinical development program for Deramiocel has focused primarily on adolescents and young adults with DMD, including many patients who are non-ambulatory and experiencing progressive cardiac and skeletal muscle decline. Its StealthX exosome platform program consists of engineered exosomes for vaccine and therapeutic development. The StealthX vaccine is a proprietary vaccine developed internally utilizing exosomes that were engineered to express either spike or nucleocapsid proteins on the surface.

Webull offers Capricor Therapeutics Inc stock information, including NASDAQ: CAPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAPR stock methods without spending real money on the virtual paper trading platform.